These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 15020033)

  • 1. Assessment of blinding in clinical trials.
    Bang H; Ni L; Davis CE
    Control Clin Trials; 2004 Apr; 25(2):143-56. PubMed ID: 15020033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An index for assessing blindness in a multi-centre clinical trial: disulfiram for alcohol cessation--a VA cooperative study.
    James KE; Bloch DA; Lee KK; Kraemer HC; Fuller RK
    Stat Med; 1996 Jul; 15(13):1421-34. PubMed ID: 8841652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding.
    Hróbjartsson A; Forfang E; Haahr MT; Als-Nielsen B; Brorson S
    Int J Epidemiol; 2007 Jun; 36(3):654-63. PubMed ID: 17440024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-trial evaluation of the potential for unblinding in drug trials: a prototype example.
    Walter SD; Awasthi S; Jeyaseelan L
    Contemp Clin Trials; 2005 Aug; 26(4):459-68. PubMed ID: 16054578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.
    Haahr MT; Hróbjartsson A
    Clin Trials; 2006; 3(4):360-5. PubMed ID: 17060210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critique of the double-blind clinical trial. Part 1.
    Kiene H
    Altern Ther Health Med; 1996 Jan; 2(1):74-80. PubMed ID: 8795875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in beliefs identify unblinding in randomized controlled trials: a method to meet CONSORT guidelines.
    Rees JR; Wade TJ; Levy DA; Colford JM; Hilton JF
    Contemp Clin Trials; 2005 Feb; 26(1):25-37. PubMed ID: 15837450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blinding in randomized clinical trials: imposed impartiality.
    Hróbjartsson A; Boutron I
    Clin Pharmacol Ther; 2011 Nov; 90(5):732-6. PubMed ID: 21993424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of risk of bias in randomized clinical trials in surgery.
    Gurusamy KS; Gluud C; Nikolova D; Davidson BR
    Br J Surg; 2009 Apr; 96(4):342-9. PubMed ID: 19283747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of clinical data with breached blindness.
    Chow SC; Shao J
    Stat Med; 2004 Apr; 23(8):1185-93. PubMed ID: 15083477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critique of the double-blind clinical trial. Part 2.
    Kiene H
    Altern Ther Health Med; 1996 Mar; 2(2):59-64. PubMed ID: 8795890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A generic minimization random allocation and blinding system on web.
    Cai H; Xia J; Xu D; Gao D; Yan Y
    J Biomed Inform; 2006 Dec; 39(6):706-19. PubMed ID: 16616696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical analysis of possible bias of clinical judgements due to observing an on-therapy marker variable.
    Boateng F; Sampson A; Schwab B
    Stat Med; 1996 Aug; 15(16):1747-55. PubMed ID: 8870157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of blinding in randomized controlled trials found results inconsistent and questionable.
    Boutron I; Estellat C; Ravaud P
    J Clin Epidemiol; 2005 Dec; 58(12):1220-6. PubMed ID: 16291465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
    Tsong Y; Zhang J
    J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods.
    Devereaux PJ; Choi PT; El-Dika S; Bhandari M; Montori VM; Schünemann HJ; Garg AX; Busse JW; Heels-Ansdell D; Ghali WA; Manns BJ; Guyatt GH
    J Clin Epidemiol; 2004 Dec; 57(12):1232-6. PubMed ID: 15617948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials.
    Boutron I; Tubach F; Giraudeau B; Ravaud P
    J Clin Epidemiol; 2004 Jun; 57(6):543-50. PubMed ID: 15246122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of blinding in clinical trials.
    Henneicke-von Zepelin HH
    Contemp Clin Trials; 2005 Aug; 26(4):512; author reply 514-5. PubMed ID: 15936250
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of bias in methodology for randomized controlled trials published on implant dentistry.
    Dumbrigue HB; Al-Bayat MI; Ng CC; Wakefield CW
    J Prosthodont; 2006; 15(4):257-63. PubMed ID: 16827739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bias in surgical research.
    Paradis C
    Ann Surg; 2008 Aug; 248(2):180-8. PubMed ID: 18650626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.